Immunohistochemical localization of FAP‐1, an inhibitor of Fas‐mediated apoptosis, in normal and neoplastic human tissues

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS)

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1699-0463.1999.tb01515.xPMID 10660140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.

  1998cited by this paper
• Fas ligand is expressed in normal skin and in some cutaneous malignancies

  1998cited by this paper
• mRNA expression of Fas receptor (CD95)‐associated proteins (Fas‐associated phosphatase‐1/FAP‐1, Fas‐associating protein with death domain/FADD, and receptor‐interacting protein/RIP) in human leukaemia/lymphoma cell lines

  1997cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997cited by this paper
• Apoptosis by death factor.

  1997cited by this paper
• Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis

  1997cited by this paper
• The Molecular Interaction of Fas and FAP-1

  1997cited by this paper
• Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.

  1996cited by this paper
• FAP-1: a protein tyrosine phosphatase that associates with Fas.

  1995cited by this paper
• CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

  1995cited by this paper
• Molecular cloning of a novel protein‐tyrosine phosphatase containing a membrane‐binding domain and GLGF repeats

  1994cited by this paper
• Purification and characterization of the Fas-ligand that induces apoptosis

  1994cited by this paper
• Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

  1994cited by this paper
• Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins.

  1994cited by this paper
• Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis.

  1994cited by this paper
• Src kinase associates with a member of a distinct subfamily of protein-tyrosine phosphatases containing an ezrin-like domain.

  1994cited by this paper
• The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice.

  1994cited by this paper
• Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

  1994cited by this paper
• Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

  1993influential reference
• A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen.

  1993cited by this paper
• Effect of bcl-2 on Fas antigen-mediated cell death.

  1993cited by this paper
• Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

  1993cited by this paper
• The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

  1991cited by this paper
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

  1991cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper
• A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

  1989cited by this paper
• Monoclonal antibody-mediated tumor regression by induction of apoptosis.

  1989cited by this paper
• Cell death: the significance of apoptosis.

  1980cited by this paper

• Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer

  2020cites this paper
• PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.

  2020cites this paper
• MiR-106a: Promising biomarker for cancer.

  2016cites this paper
• Non-transmembrane PTPs in Cancer

  2016cites this paper
• Protein Tyrosine Phosphatases in Cancer

  2016cites this paper
• Protein phosphatases in pancreatic islets.

  2014cites this paper
• miR‐106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS

  2013cites this paper
• Fas ligand(+) fallopian tube epithelium induces apoptosis in both Fas receptor(+) T lymphocytes and endometrial cells.

  2013cites this paper
• Reactive oxygen species induced oxidative stress, neuronal apoptosis and alternative death pathways

  2013cites this paper
• Prognostic Significance of PUMA in Pancreatic Ductal Adenocarcinoma

  2012cites this paper
• Helicobacter Infection: Infection, Immunity and the Progression of Lesions to Invasive Gastric Cancer

  2011cites this paper
• PTPN13/PTPL1: an important regulator of tumor aggressiveness.

  2011cites this paper
• FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.

  2011cites this paper
• Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin.

  2010cites this paper
• Pathogenesis of the Helicobacter Induced Mucosal Disease: A Dissertation

  2010cites this paper
• Organelle dynamics and membrane trafficking in apoptosis and autophagy.

  2010cites this paper
• Resistance to chemotherapy and hormone therapy in endometrial cancer.

  2009cites this paper
• Expressional and Mutational Analysis of Pro-apoptotic Bcl-2 Member PUMA in Hepatocellular Carcinomas

  2008cites this paper
• The protein tyrosine phosphatase-BL, modulates pancreatic beta-cell proliferation by interaction with the Wnt signalling pathway.

  2008cites this paper
• Mutational analysis of FLASH and PTPN13 genes in colorectal carcinomas

  2008cites this paper
• Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers.

  2007cites this paper
• FAP‐1‐mediated activation of NF‐κB induces resistance of head and neck cancer to fas‐induced apoptosis

  2007cites this paper
• Transcriptomic assessment of quinone mediated hepatic oxidative stress

  2007cites this paper
• Poster 032: Expression of FAP-1 Associated With Prognosis in Oral Squamous Cell Carcinoma

  2007cites this paper
• Expression of phosphorylated caspase‐9 in gastric carcinomas

  2007cites this paper
• Ionizing radiation suppresses FAP‐1 mRNA level in A549 cells via p53 activation

  2006cites this paper
• Major Histocompatibility Complex Class II Inhibits Fas Antigen-Mediated Gastric Mucosal Cell Apoptosis through Actin-Dependent Inhibition of Receptor Aggregation

  2005cites this paper
• Immunohistochemical Localization of Fas-Associated Phosphatase-1 (FAP-1) in Alzheimer Disease Hippocampus

  2005influential citation
• Significance of Fas receptor protein expression in epithelial ovarian cancer.

  2005cites this paper
• Loss of caspase‐2, ‐6 and ‐7 expression in gastric cancers

  2004cites this paper
• Expression of adhesion molecules and Ki-67 in female adnexal tumor of probable Wolffian origin (FATWO): report of two cases and review of the literature.

  2004cites this paper
• Mutation of FADD gene is rare in human colon and stomach cancers

  2004cites this paper
• Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer

  2004cites this paper
• [PTPL1, a proapoptotic protein tyrosine phosphatase in breast cancers].

  2004cites this paper
• Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling.

  2004cites this paper
• Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer

  2003cites this paper
• Increased expression of FLIP, an inhibitor of Fas‐mediated apoptosis, in stomach cancer

  2003cites this paper
• Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas

  2003cites this paper
• FAP-1 Association with Fas (Apo-1) Inhibits Fas Expression on the Cell Surface

  2003cites this paper
• Stomach cancer highly expresses both initiator and effector caspases; an immunohistochemical study

  2002cites this paper
• Defining the dynamics of self-assembled Fas-receptor activation.

  2002cites this paper
• Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis

  2002influential citation
• Pro-apoptotic and anti-apoptotic effects of transferrin and transferrin-derived glycans on hematopoietic cells and lymphocytes.

  2001cites this paper
• Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer.

  2001cites this paper
• Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits.

  2001cites this paper
• [Apoptosis and the thyroid: the Fas pathway].

  2001cites this paper
• Negative regulation of Fas‐mediated apoptosis by FAP‐1 in human cancer cells

  2000cites this paper